Hillsdale Investment Management’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
Other funds holding PBH
AI
Hillsdale Investment Management's PBH Position: Q2 2024 in Review
Hillsdale Investment Management sold out of Prestige Consumer Healthcare (PBH) in Q2 2024, closing a stake of 83,600 shares — an estimated $6.07M sold.
Hillsdale Investment Management first reported a position in PBH in Q1 2016 and held it in 19 quarters. The position peaked at $6.34M in Q2 2022. 306 funds tracked by Wall St. Rank hold PBH as of Q2 2024.
- Hillsdale Investment Management reported no remaining Prestige Consumer Healthcare position as of Q2 2024 after selling out during the quarter.
- Hillsdale Investment Management sold 83,600 Prestige Consumer Healthcare shares in Q2 2024, an estimated $6.07M.
- Hillsdale Investment Management first reported a position in Prestige Consumer Healthcare in Q1 2016 and held it in 19 quarters.
- Hillsdale Investment Management's Prestige Consumer Healthcare position peaked at $6.34M in Q2 2022.
- 306 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2024.
Based on Hillsdale Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.